These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 6141189

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Tardive dyskinesia in schizophrenic outpatients: prevalence and significant variables.
    Ezrin-Waters C, Seeman MV, Seeman P.
    J Clin Psychiatry; 1981 Jan; 42(1):16-22. PubMed ID: 6109715
    [Abstract] [Full Text] [Related]

  • 4. Prevention and management of tardive dyskinesia.
    Jeste DV, Wyatt RJ.
    J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):14-8. PubMed ID: 2858473
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Neuroleptic drugs: how to reduce the risk of tardive dyskinesia.
    DeVeaugh-Geiss J.
    Geriatrics; 1979 Jul; 34(7):59-61, 66. PubMed ID: 36330
    [Abstract] [Full Text] [Related]

  • 7. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
    Villeneuve A, Lajeunesse C.
    Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
    [Abstract] [Full Text] [Related]

  • 8. [Occurrence of tardive dyskinesia during neuroleptic treatment].
    Fanget F, Henry E, Aimard G.
    Presse Med; 1986 Dec 06; 15(43):2147-50. PubMed ID: 2884657
    [Abstract] [Full Text] [Related]

  • 9. Tardive dyskinesia and depressive illness.
    Davis KL, Berger PA, Hollister LE.
    Psychopharmacol Commun; 1976 Dec 06; 2(2):125-30. PubMed ID: 10603
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Relationship between neuroleptic extrapyramidal syndromes and patients' all-cause mortality.
    Modestin J, Vogt Wehrli M, Stephan PL, Agarwalla P.
    Pharmacopsychiatry; 2009 Mar 06; 42(2):57-60. PubMed ID: 19308879
    [Abstract] [Full Text] [Related]

  • 19. Tardive dyskinesia and plasma homovanillic acid.
    Moore DC, Glazer WM, Bowers MB, Heninger GR.
    Biol Psychiatry; 1983 Dec 06; 18(12):1393-402. PubMed ID: 6140961
    [Abstract] [Full Text] [Related]

  • 20. Late onset involuntary movements in chronic schizophrenia: age-related vulnerability to 'tardive' dyskinesia independent of extent of neuroleptic medication.
    Waddington JL, Youssef HA.
    Ir Med J; 1985 May 06; 78(5):143-6. PubMed ID: 2861172
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.